Pacira Pharmaceuticals Statement on FDA Advisory Committee for EXPAREL® for Use as a Nerve Block to Produce Regional Analgesia

Go back to Pacira Pharmaceuticals Statement on FDA Advisory Committee for EXPAREL® for Use as a Nerve Block to Produce Regional Analgesia
PACIRA (NASDAQ: PCRX) Delayed: 24.70 +0.59 (2.45%)
Previous Close $24.11    52 Week High $80.25 
Open $24.36    52 Week Low $30.25 
Day High $24.97    P/E N/A 
Day Low $24.20    EPS $-2.08 
Volume 380,504